Dopaminergic agents for the treatment of cocaine abuse

Drug Discovery Today

Volumn 4, Issue 7, 1999, Pages 322-332

  Smith, Miles P ^a   Hoepping, Alexander ^a   Johnson, Kenneth M ^b   Trzcinska, Monika ^c   Kozikowski, Alan P ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMANTADINE; AMFEBUTAMONE; AUTORECEPTOR; BENZATROPINE; BROMOCRIPTINE; COCAINE; DESIPRAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; FENFLURAMINE; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; IBOGAINE; MAZINDOL; METHADONE; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; NICOTINE; NORADRENALIN; NORTROPANE DERIVATIVE; PSEUDOCOCAINE; UNINDEXED DRUG; VANOXERINE;

BINDING AFFINITY; COCAINE DEPENDENCE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; HUMAN; NONHUMAN; REVIEW; WITHDRAWAL SYNDROME;

EID: 0033168395     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(99)01332-X     Document Type: Review

References (114)

1. 1 Lounasmaa, M. (1988) The Alkaloids 33, 1-81
2. 2 Caine, C.B. (1998) Nat. Neurosci. 1, 90-92
3. 3 Fishman, M.W. and Schuster, C.R. (1982) Fed. Proc. 41, 241-246
4. 4 Mathews, J.C. and Collins, A. (1983) Biochem. Pharmacol. 32, 455-460
5. 5 Di Chiara, G. and Imperato, A. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 5274-5278
6. 6 Kuhar, M.J. et al. (1991) Trends Neurosci. 14, 299-301
7. 7 Esposito, R.U., Motola, A.H. and Kornetsky, C. (1978) Pharm. Biochem. Behav. 8, 437-439
8. 8 Frank, R.A. et al. (1992) Pharm. Biochem. Behav. 42, 771-779
9. 9 Markou, A. and Koob, G.F. (1991) Neuropsychopharmacology 4, 17-26
10. 10 Kornetsky, C. and Esposito, R.U. (1981) Brain Res. 209, 496-500
11. 11 Pettit, H.O. and Justice, J.B., Jr (1989) Pharmacol. Biochem. Behav. 34, 899-904
12. 12 Imperato, A. (1992) Eur. J. Pharmacol. 212, 299-300
13. 13 Wise, R.A. et al. (1995) Psychopharmacology 120, 10-20
14. 14 Uhl, G. et al. (1998) Methods Enzymol. 296, 456-465
15. 15 Herz, A. (1998) Can. J. Phys. Pharmacol. 76, 252-258
16. 16 Chait, L.D., Uhlenhuth, E.H. andjohanson, C.E. (1987) J. Pharmacol. Exp. Ther. 242, 777-783
17. 17 Shuster, L. (1991) in Cocaine: Pharmacology, Physiology and Clinical Stratagies (Lakoski, J.M., Galloway, M.P. and White, F.J., eds), pp. 1-14, CRC Press
18. 18 Gorelick, D.A. (1998) Adv. Pharmacol. 42, 995-1001
19. 19 Giros, B. et al. (1996) Nature 379, 606-612
20. 20 Sora, I. et al. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 7699-7704
21. 21 Rocha, B.A. et al. (1998) Nat. Neurosci. 1, 132-135
22. 22 Rocha, B.A. et al. (1998) Nature 393, 175-178
23. 23 McGregor, A., Lococta, S. and Roberts, D.C.S. (1993) Pharmacol. Biochem. Behav. 44, 651-655
24. 24 Richardson, N.R. and Roberts, D.C.S. (1991) Life Sci. 49, 833-840
25. 25 Gerrits, M.A.F. et al. (1995) Psychopharmacology 119, 92-98
26. 26 Glowa, J.R. et al. (1997) Exp. Opin. Ther. Pat. 7, 1459-1476
27. 27 Nathan, C.I., Bresnick, W.H. and Batki, S.L. (1998) CNS Drugs 10, 43-59
28. 28 Klein, M. (1998) Ann. New York Acad. Sci. 844, 75-91
29. 29 Koob, G.F. (1998) Adv. Pharmacol. 42, 969-1001
30. 30 Ali, S.F. (1998) Ann. New York Acad. Sci. 844, 122-130
31. 31 Self, D.W. and Nestler, E.J. (1995) Annu. Rev. Neurosci. 18, 463-469
32. 32 Self, D.W. et al. (1996) Science 271, 1586-1589
33. 33 Moore, R.J. et al. (1998) Synapse 28, 1-9
34. 34 Weed, M.R. and Woolverton, W.L. (1995) J. Pharmacol. Exp. Ther. 275, 1367-1374
35. 35 Self, D.W. and Stein, L. (1992) Brain Res. 582, 349-352
36. 36 Jensen, A.A. et al. (1996) Biochem. Soc. Trans. 24, 163-169
37. 37 Tennant, F.S. and Sagherinan, A. (1987) Arch. Intern. Med. 147, 109-112
38. 38 Moscovitz, H., Brookoff, D. and Nelson, L. (1993) J. Gen. Intern. Med. 8, 1-4
39. 39 McCane, E.F. (1997) NIDA Research Mono. 175, 36-72
40. 40 Preston, K.L. et al. (1992) J. Pharmacol. Exp. Ther. 262, 279-291
41. 41 Piercey, M.F. et al. (1992) Brain Res. 588, 217-222
42. 42 Caine, S.B. et al. (1997) NeuroReport 8, 2373-2377
43. 43 Sherer, M.A., Kumor, K.M. and Jaffe, J.H. (1989) Psychiatry Res. 27, 117-125
44. 44 Kosten, T.A. et al. (1996) Psychopharmacology 128, 304-312
45. 45 LeDuc, P.A. and Mittleman, G. (1993) Psychopharmacology 110, 427-436
46. 46 Ohuoha, D.C. et al. (1997) J. Subst. Abuse Treat. 14, 249-258
47. 47 Gawin, F.H. (1991) Science 251, 1580-1586
48. 48 Waymet, H., Meiergerd, S.M. and Schenk, J.O. (1998) J. Neurochem. 70, 1941-1949
49. 49 Missale, C. et al. (1985) J. Neurochem. 45, 51-56
50. 50 McElvain, J.S. and Schenk, J.O. (1992) Pharmacologist 43, 2189-2199
51. 51 Giros, B. et al. (1994) J. Biol. Chem. 269, 15985-15988
52. 52 Rothman, R.B. (1990) Life Sci. 46, 17-21
53. 53 Chiat, L.H., Uhlenhuth, E.H. andjohanson, C.D. (1987) J. Pharmacol. Exp. Ther. 242, 777-783
54. 54 Mansbach, R.S. and Blaster, R.L. (1993) Drug Alcohol Depend. 31, 183-191
55. 55 Preston, K.L. et al. (1993) J. Pharmacol. Exp. Ther. 267, 296-307
56. 56 Malison, R.T. et al. (1998) Psychopharmacology 137, 321-325
57. 57 Miller, L. and Griffith, J. (1983) Psychopharmacology 80, 199-205
58. 58 Margolin, A. et al. (1991) Arch. Gen. Psychiatry 48, 87
59. 59 Margolin, A. et al. (1995) Drug Alcohol Depend. 40, 125-131
60. 60 Grabowski, J. et al. (1997) J. Clin. Psychopharmacol. 17, 485-488
61. 61 Deutsch, H.M. et al. (1996) J. Med. Chem. 39, 1201-1209
62. 62 Matecka, D. et al. (1996) J. Med. Chem. 39, 4704-4716
63. 63 Dutta, A.K., Xu, C. and Reith, M.E.A. (1996) J. Med. Chem. 39, 749-756
64. 64 Matecka, D. et al. (1997) J. Med. Chem. 40, 705-716
65. 65 Dutta, A.K., Coffey, L.L. and Reith, M.E.A. (1998) J. Med. Chem. 41, 699-705
66. 66 Maldonado-Irizzary, C.S., Stellar, J.R. and Kelley, A.E. (1994) Pharm. Biochem. Behav. 48, 915-920
67. 67 Glowa, J.R. et al. (1995) Exp. Clin. Psychopharmacol. 3, 219-231
68. 68 Rothman, R.B. et al. (1992) Pharmacol. Biochem. Behav. 43, 1135-1142
69. 69 Rothman, R.B. et al. (1991) Pharmacol. Biochem. Behav. 40, 387-397
70. 70 Baumann, M.H. et al. (1994) J. Pharmacol. Exp. Ther. 271, 1216-1222
71. 71 Gifford, A.N., Bergmann J.S. and Johnson K.M. (1993) Drug Alcohol Depend. 32, 65-71
72. 72 Glowa, J.R. et al. (1996) J. Med. Chem. 39, 4689-4691
73. 73 Kline, R.H. et al. (1997) J. Med. Chem. 40, 851-857
74. 74 Agoston, G.E. et al. (1997) J. Med. Chem. 40, 4329-4339
75. 75 Meltzer, P.C., Liang, A.Y. and Madras, B.K. (1994) J. Med. Chem. 37, 2001-2010
76. 76 Acri, J.B. et al. (1996) J. Pharmacol. Exp. Ther. 277, 198-206
77. 77 Newman, A.H. et al. (1994) J. Med. Chem. 37, 2258-2261
78. 78 Carroll, F.I. et al. (1992) J. Med. Chem. 35, 969-981
79. 79 Meltzer, P.C., Blundell, P. and Madras, B.K. (1998) Med. Chem. Res. 8, 12-34
80. 80 Smith, M.P. et al. (1998) J. Am. Chem. Soc. 120, 9072-9073
81. 81 Lomenzo, S.A. et al. (1997) J. Med. Chem. 40, 4406-4414
82. 82 Rieth, M.E. et al. (1986) Biochem. Pharmacol. 35, 1123-1129
83. 83 Meltzer, P.C., Blundell, P. and Madras, B.K. (1998) Med. Chem. Res. 8, 12-34
84. 84 Davies, H.M.L. et al. (1994) J. Med. Chem. 37, 1262-1268
85. 85 Davies, H.M.L. et al. (1996) J. Med. Chem. 39, 2554-2558
86. 86 Blough, B.E. et al. (1997) J. Med. Chem. 40, 3861-3864
87. 87 Chang, A.C. et al. (1997) J. Med. Chem. 40, 1247-1251
88. 88 Kozikowski, A.P. et al. (1998) J. Med. Chem. 41, 4973-4982
89. 89 Kozikowski, A.P. et al. (1992) J. Med. Chem. 35, 4764-4766
90. 90 Carroll, F.I. et al. (1994) J. Med. Chem. 37, 2865-2873
91. 91 Meegalla, S.K. et al. (1997) J. Med. Chem. 40, 9-17
92. 92 Hoepping, A. et al. (1998) J. Med. Chem. 41, 4429-4432
93. 93 Madras, B.K. et al. (1996) Synapse 22, 239-246
94. 94 Smith, M.P., George, C. and Kozikowski, A.P. (1998) Tetrahedron Lett. 39, 197-200
95. 95 Kozikowski, A.P. et al. (1994) J. Med. Chem. 37, 3440-3442
96. 96 Stoelwinder, J. et al. (1994) Bioorg. Med. Chem. Lett. 4, 303-308
97. 97 Meltzer, P.C. et al. (1997) J. Med. Chem. 40, 2661-2673
98. 98 Simoni, D. et al. (1993) J. Med. Chem. 36, 3975-3977
99. 99 Prakash, K.R.C. et al. (1998) Med. Chem. Res. 8, 43-58
100. 100 Kozikowski, A.P. et al. (1998) J. Med. Chem. 41, 1962-1969
101. 101 Nader, M.A. et al. (1997) J. Pharm. Exp. Ther. 280, 541-550
102. 102 Duanais, J.B. et al. (1998) J. Pharm. Exp. Ther. 285, 1246-1254
103. 103 Click, S.D. and Maisonneuve, I.M. (1998) Ann. New York Acad. Sci. 844, 214-226
104. 104 Click, S.D. et al. (1994) Brain Res. 657, 14-22
105. 105 Dewy, S.L. et al. (1992) J. Neurosci. 12, 3773-3780
106. 106 Morgan, A.E. and Dewey, S.L. (1998) Synapse 28, 60-65
107. 107 Wegelius, K., Halonene, T. and Korpi, E.R. (1993) Pharmacol. Toxicol. 73, 150-152
108. 108 Backus, L.I. et al. (1988) Pharmacol. Biochem. Behav. 30, 657-663
109. 109 Kushner, S.A., Dewey, S.L. and Kornetsky, C. (1997) Psychopharmacology 133, 383-388
110. 110 Alterman, A.I. et al. (1992) Drug Alcohol Depend. 31, 19-29
111. 111 Rothman, R.B. et al. (1998) Ann. New York Acad. Sci. 844, 59-74
112. 112 Hitzg, P. (1994) J. Subst. Abuse Treat. 11, 489-490
113. 113 Haberny, K.A. (1995) Drug Alcohol Depend. 39, 55-62
114. 114 Batki, S.L. et al. (1996) Drug Alcohol Depend. 41, 137-142